Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances BioVie Inc BIVI Q1 2026 Earnings Narrowing Losses and Clinical Progress Buoy Investor Sentiment PLX Q1 2026 Earnings Major EPS Beat Driven by Strong Operational Performance DFTX Q1 2026 Earnings EPS Misses Estimates by 4143 as PreRevenue Biotech Reports Wider Loss IDEX Corporation Q1 2026 Earnings EPS Surpasses Estimates by 117 Talphera Inc TLPH Q1 2026 Earnings Narrower Loss Surprises Analysts as Company Advances Pipeline